Log in
Register
SearchFDA views on the use of R and other nonproprietary software [Software]
Hi all,
I stumbled upon this presentation by chance.
The future looks bright for R.
A good weekend to all of you.
I stumbled upon this presentation by chance.
The future looks bright for R.
A good weekend to all of you.
—
Best regards,
ElMaestro
"(...) targeted cancer therapies will benefit fewer than 2 percent of the cancer patients they’re aimed at. That reality is often lost on consumers, who are being fed a steady diet of winning anecdotes about miracle cures." New York Times (ed.), June 9, 2018.
if (3) 4
x=c("Foo", "Bar")
b=data.frame(x)
typeof(b[,1]) ##aha, integer?
b[,1]+1 ##then let me add 1
Best regards,
ElMaestro
"(...) targeted cancer therapies will benefit fewer than 2 percent of the cancer patients they’re aimed at. That reality is often lost on consumers, who are being fed a steady diet of winning anecdotes about miracle cures." New York Times (ed.), June 9, 2018.
Complete thread:
- FDA views on the use of R and other nonproprietary software - ElMaestro, 2017-11-24 19:33
![[Mix]](https://static.bebac.at/img/mix.png "open in mix view")
Admin contact
